Food & BevHealth & Wellness
Adaptyv Biosystems
We use synthetic biology and nanofluidics for next-gen protein engineering
Wilmington,
DE
Investment type:
Equity
(SAFE)
Target raise:
$50,000
- $107,000
Minimum investment:
$100
$100
End date:
Mar 22, 2022
Mar 22, 2022
ended
Share
Highlights
- In the future, all proteins will be made using cell-free synthetic biology
- We are building the best platform to engineer proteins based on high-throughput nanofluidics
- This way we generate the data needed for training ML models that can predict new protein designs
- Our platform develops better therapies against targets in cancer, autoimmune & rare diseases
Our Story
Develop a platform to synthesize and characterize thousands of proteins in high-throughput to understand how to engineer better therapeutics.
Our Ambition
Our nanofluidic platform will be running 24/7, generating data about the behavior of millions of new protein designs. Our AI learns from all that data and has thus become the operating system for protein engineers worldwide.